Literature DB >> 19807240

The role of fentanyl in cancer-related pain.

Eric Prommer1.   

Abstract

Fentanyl is a lipophilic, short-acting, synthetic opioid with a piperidine chemical structure. Fentanyl is an effective analgesic for cancer pain, and newer formulations such as the transmucosal and buccal forms have shown efficacy for the management of cancer-related breakthrough pain. This article reviews the pharmacodynamics, pharmacology, and clinical efficacy for this new option in treating moderate to severe pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807240     DOI: 10.1089/jpm.2009.0051

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  14 in total

Review 1.  [Cancer breakthrough pain. Indications for rapidly effective opioids].

Authors:  J Kessler; H J Bardenheuer
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

Review 2.  Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.

Authors:  Frank Elsner; Giovambattista Zeppetella; Josep Porta-Sales; Ignacio Tagarro
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  [Neuropathic and tumour-induced headache: Therapeutic options].

Authors:  A Wagner; J A Blunk; J Benrath
Journal:  HNO       Date:  2011-07       Impact factor: 1.284

Review 4.  Fentanyl pectin nasal spray: in breakthrough pain in opioid-tolerant adults with cancer.

Authors:  Katherine A Lyseng-Williamson
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

5.  Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.

Authors:  Harold Minkowitz; Janet Bull; R Charles Brownlow; Neha Parikh; Richard Rauck
Journal:  Support Care Cancer       Date:  2016-01-16       Impact factor: 3.603

Review 6.  Fentanyl for the treatment of tumor-related breakthrough pain.

Authors:  Helmar Bornemann-Cimenti; Mischa Wejbora; Istvan S Szilagyi; Andreas Sandner-Kiesling
Journal:  Dtsch Arztebl Int       Date:  2013-04-19       Impact factor: 5.594

7.  Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update.

Authors:  Marvin Omar Delgado-Guay
Journal:  Cancer Manag Res       Date:  2010-11-24       Impact factor: 3.989

8.  Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2011-01

9.  Role of intranasal fentanyl in breakthrough pain management in cancer patients.

Authors:  Wojciech Leppert
Journal:  Cancer Manag Res       Date:  2010-09-30       Impact factor: 3.989

10.  Efficacy and Safety of Fentanyl Compared With Morphine among Adult Patients with Cancer: A Meta-Analysis.

Authors:  Astère Manirakiza; Laurent Irakoze; Sébastien Manirakiza; Prudence Bizimana
Journal:  East Afr Health Res J       Date:  2020-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.